Načítá se...
Identification of adenosquamous carcinoma as a rare aggressive HER2-negative subgroup of esophageal/gastroesophageal junction adenocarcinoma
BACKGROUND: Our purpose was to evaluate the prognostic impact of pathologically-confirmed esophageal adenosquamous carcinoma (ASC) and its association with HER2 status and clinicopathologic characteristics. METHODS: Among 796 patients with esophageal or gastroesophageal junction (GEJ) adenocarcinoma...
Uloženo v:
| Vydáno v: | Am J Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546176/ https://ncbi.nlm.nih.gov/pubmed/30516569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000495 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|